Cargando…

Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis

RATIONALE: Pulmonary Alveolar Proteinosis (PAP) patients exhibit an acquired deficiency of biologically active granulocyte-macrophage colony stimulating factor (GM-CSF) attributable to GM-CSF specific autoantibodies. PAP alveolar macrophages are foamy, lipid-filled cells with impaired surfactant cle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malur, Anagha, Kavuru, Mani S, Marshall, Irene, Barna, Barbara P, Huizar, Isham, Karnekar, Reema, Thomassen, Mary Jane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432632/ https://www.ncbi.nlm.nih.gov/pubmed/22697800 http://dx.doi.org/10.1186/1465-9921-13-46

Ejemplares similares

Carbon Nanotube-Induced Pulmonary Granulomatous Disease: Twist1 and Alveolar Macrophage M1 Activation
por: Barna, Barbara P., et al.
Publicado: (2013)

Alveolar macrophages of GM-CSF knockout mice exhibit mixed M1 and M2 phenotypes
por: Dalrymple, Heidi, et al.
Publicado: (2013)

Sarcoidosis activates diverse transcriptional programs in bronchoalveolar lavage cells
por: Gharib, Sina A., et al.
Publicado: (2016)

Rituximab rescue therapy for autoimmune pulmonary alveolar proteinosis
por: Bird, Daniel, et al.
Publicado: (2022)

Alveolar macrophages in pulmonary alveolar proteinosis: origin, function, and therapeutic strategies
por: Huang, Xinmei, et al.
Publicado: (2023)

Atypical alveolar proteinosis
por: Rajaonarison Ny Ony Narindra, Lova Hasina, et al.
Publicado: (2018)

The role of PPARγ in carbon nanotube-elicited granulomatous lung inflammation
por: Huizar, Isham, et al.
Publicado: (2013)

Impaired lipid metabolism in idiopathic pulmonary alveolar proteinosis
por: Tian, Xinlun, et al.
Publicado: (2011)

Rituximab for auto-immune alveolar proteinosis, a real life cohort study
por: Soyez, Berenice, et al.
Publicado: (2018)

Alveolar proteinosis in Behçet's disease
por: Tetikkurt, Cuneyt, et al.
Publicado: (2010)

Congenital Pulmonary Alveolar Proteinosis
por: Hammami, Saber, et al.
Publicado: (2013)

Pulmonary alveolar proteinosis in children
por: Bush, Andrew, et al.
Publicado: (2020)

Alveolar proteinosis of genetic origins
por: Hadchouel, Alice, et al.
Publicado: (2020)

Pulmonary Alveolar Proteinosis Refractory to Plasmapheresis and Rituximab despite GM-CSF Antibody Reduction
por: Keske, Aysenur, et al.
Publicado: (2022)

Clinical significance of serum lipids in idiopathic pulmonary alveolar proteinosis
por: Fang, Cun S, et al.
Publicado: (2012)

Lipid-Laden Macrophages Are Not Diagnostic of Pulmonary Alveolar Proteinosis Syndrome and Can Indicate Lung Injury
por: McCarthy, Cormac, et al.
Publicado: (2020)

Pulmonary alveolar proteinosis in a cat
por: Szatmári, Viktor, et al.
Publicado: (2015)

Pulmonary Alveolar Proteinosis with Ulcerative Colitis
por: Sakamoto, Noriho, et al.
Publicado: (2018)

Pulmonary alveolar proteinosis with peripheral adenocarcinom
por: Zhang, Ning, et al.
Publicado: (2018)

Autoimmune pulmonary alveolar proteinosis in children
por: Griese, Matthias, et al.
Publicado: (2022)

Elemental analysis of lung tissue particles and intracellular iron content of alveolar macrophages in pulmonary alveolar proteinosis
por: Shimizu, Yasuo, et al.
Publicado: (2011)

Altered macrophage phenotypes in a case of autoimmune pulmonary alveolar proteinosis
por: Hata, Kentaro, et al.
Publicado: (2023)

Peripheral alveolar nitric oxide concentration reflects alveolar inflammation in autoimmune pulmonary alveolar proteinosis
por: Hirano, Taizou, et al.
Publicado: (2018)

The Alveolar Lipidome in Pulmonary Alveolar Proteinosis. A New Target for Therapeutic Development?
por: Trapnell, Bruce C., et al.
Publicado: (2019)

Whole lung lavage for pulmonary alveolar proteinosis
por: Jayaraman, S., et al.
Publicado: (2010)

Pulmonary alveolar proteinosis: diagnostic and therapeutic challenges
por: Campo, Ilaria, et al.
Publicado: (2012)

Lung Transplant Recipient with Pulmonary Alveolar Proteinosis
por: Tokman, Sofya, et al.
Publicado: (2016)

Prevalence and healthcare burden of pulmonary alveolar proteinosis
por: McCarthy, Cormac, et al.
Publicado: (2018)

Alveolar proteinosis due to toxic inhalation at workplace
por: Santos, Gabriela F., et al.
Publicado: (2020)

Pulmonary alveolar proteinosis: from classification to therapy
por: Salvaterra, Elena, et al.
Publicado: (2020)

Valuable Serum Markers in Pulmonary Alveolar Proteinosis
por: Shi, Shenyun, et al.
Publicado: (2019)

Pulmonary alveolar proteinosis after lung transplantation
por: Divithotawela, Chandima, et al.
Publicado: (2020)

Pulmonary alveolar proteinosis with an unusual bronchoscopic complication
por: Sweeney, Duncan J., et al.
Publicado: (2021)

Alveolar proteinosis - an underdiagnosed condition in young people
por: Chiş, Ana Florica, et al.
Publicado: (2021)

Sirolimus-induced secondary pulmonary alveolar proteinosis
por: Wang, Stephanie, et al.
Publicado: (2021)

Alveolar Proteinosis in COVID-19: Clinical Case
por: Martin Bote, Silvia, et al.
Publicado: (2022)

Iron homeostasis and oxidative stress in idiopathic pulmonary alveolar proteinosis: a case-control study
por: Ghio, Andrew J, et al.
Publicado: (2008)

Pulmonary alveolar proteinosis in children: a case series
por: Tabatabaei, Seyyed Ahmad, et al.
Publicado: (2010)

Pulmonary alveolar proteinosis treatment by whole-lung lavage
por: Cai, Chang, et al.
Publicado: (2012)

Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis
por: McCarthy, Cormac, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5u36e2pgcdpn07l1pd1sc0jbke